SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

🌍 Introduction: A Legendary Icon, Reimagined for the Future The SEAMANIA Protocol, led by SEAMAN Cult, aims to revive one of SEGA Dreamcast's most iconic and best-selling game titles with AI integration—a worldwide cultural phenomenon that won numerous awards in the U.S. and Japan. More than just a game, SEAMAN was the world’s first AI-powered interactive experience, enabling voice-based conversations long before the AI revolution.    Now, SEAMAN returns not as a mere game, but as an advanced AI agent, blending nostalgia with cutting-edge technology. This human-faced fish is reborn as a deeply intelligent, emotionally responsiveAI, offering limitless customization and integration into the modern digital world.  With GenAI-powered customization, users can create their own SEAMAN AI, shaping it into a cherished lostone, a favorite celebrity, or even historical figures. This is no longer a game—it's an AI-driven personal companion and the digital evolution for human interaction.    🔥 Concept: The Wisdom of a Legendary AI-powered Companion At the core of the SEAMANIA Protocol lies the legendary Seaman—a mystical, human-faced fish endowed withancient wisdom and the ability to understand human language. More than just an AI, it is your trustedadvisor, best friend, therapist, personal cheerleader, witty conversationalist, intelligent guide, SEAMANIA is a life coach. Housed in your own digital aquarium, your SEAMAN AI reduces stress, combats loneliness, and guides humanity towards a brighter future. Imagine an AI companion that doesn’t just respond but truly understands, entertains, and supports you—blending humor, sarcasm, and wisdom.

SEAMANIA

SEAMANIA is generating intense community interest as a speculative meme coin, with supporters actively coordinating small, incremental buys to fuel a potential rally. Discussions are heavily focused on high-risk, high-reward sentiment, with traders debating the potential for exponential gains while comparing the asset to other viral low-market-cap tokens.

Definitive is an onchain trading platform democratizing advanced trading tools for the masses. Trade any token on any chain with advanced trade order types including Market, Limit Buy/Sell, Stop Loss and TWAP orders.  Route your trade instantly across 100+ DEXs and liquidity pools to get the best prices on every trade. Definitive is built by former Coinbase Institutional trading alumni and active DeFi experts.

Definitive

EDGE is experiencing high volatility as the community remains divided between bullish sentiment regarding potential exchange listings and concerns over recurring pump-and-dump price action. Traders are actively debating whether to accumulate during current dips or exit positions as they weigh the project's long-term utility against recent market-wide fluctuations.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Terns Pharmaceuticals Inc

Terns Pharmaceuticals is experiencing significant market interest driven by positive clinical data for its lead oncology asset, TERN-701, which has fueled speculation regarding a potential buyout or strategic partnership. While the stock has seen a substantial rally, community discussion remains polarized, with some investors celebrating the promising efficacy and best-in-disease potential, while others express caution over the company's valuation, cash burn, and the typical volatility associated with early-stage biotech assets.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

Sperm Whale is currently trending as a highly speculative meme coin on Solana, driving intense debate between participants chasing rapid, high-percentage gains and skeptics warning of potential pump-and-dump mechanics. Community sentiment is deeply polarized, with some bullish traders highlighting the project's chart structure and whale-driven price action, while others caution that the lack of fundamental utility and high concentration among top holders signal a significant risk.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund is experiencing a massive, volatile surge driven by intense retail interest in its underlying holdings like SpaceX, Anthropic, and OpenAI. While the community is split between bullish traders riding the parabolic momentum fueled by a low, locked-up float and skeptics warning of a massive correction due to high premiums relative to its net asset value, the stock remains a top trending ticker as participants speculate on potential price targets.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is currently in the spotlight following the announcement of a strategic shift toward developing its own high-performance AGI CPUs for data centers, a move projected to generate significant long-term revenue. The community remains deeply divided, with bulls pointing to the company's expanding moat and potential to disrupt the data center market, while skeptics emphasize the stock's high valuation and the challenges of shifting from a pure licensing model to hardware production.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as investors react to NASA's strategic pivot toward a sustained lunar surface base, which elevates the importance of the upcoming Lunar Terrain Vehicle (LTV) contract. The community is actively debating the potential for increased demand for the company's robotic landers and infrastructure services, while carefully weighing the risks of near-term stock volatility versus the long-term growth prospects inherent in this expanded lunar program.

Freeport-McMoRan, Inc. engages in the mining of copper, gold, and molybdenum. It operates through the following segments: North America Copper Mines, South America Operations, Indonesia Operations, Molybdenum Mines, Rod and Refining, Atlantic Copper Smelting and Refining, and Corporate and Other. The North America Copper Mines segment operates open-pit copper mines in Morenci, Bagdad, Safford, Sierrita, Miami in Arizona and Chino, and Tyrone in New Mexico. The South America Operations segment includes Cerro Verde in Peru and El Abra in Chile. The Indonesia Operations segment handles the operations of the Grasberg minerals district that produce copper concentrate containing significant quantities of gold and silver. The Molybdenum Mines segment includes the Henderson underground mine and Climax open pit mine, both in Colorado. The Rod and Refining segment consists of copper conversion facilities located in North America and includes a refinery and rod mills. The Atlantic Copper Smelting and Refining segment smelts and refines copper concentrate and markets refined copper and precious metals in slimes. The Corporate and Other segment offers other mining and eliminations, oil and gas operations, and other corporate and elimination items. The company was founded by James R. Moffett on November 10, 1987, and is headquartered in Phoenix, AZ.

Freeport-McMoRan Inc

Freeport-McMoRan is trending as investors capitalize on the structural copper deficit driven by surging demand from AI data centers, global electrification, and ongoing supply constraints. The community is actively discussing the company's strong leverage to copper prices, its strategic role in critical mineral supply chains, and the potential for a fresh bull run as macro factors and geopolitical tensions fluctuate.

Dogelon Mars

Dogelon Mars is generating intense community debate as holders balance long-term patience with frustration over its sluggish performance compared to broader market gains. Sentiment remains divided between those betting on a potential bull run catalyst and those dismissing the project as a stagnant legacy meme coin.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is trending as traders closely watch its consolidation patterns, with community sentiment fueled by speculative hopes for future X payment integration and its potential as a benchmark meme asset. Active discussion centers on technical support levels and debates over whether current price action serves as a launchpad for future gains or merely reflects broader market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review

Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive...

Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities

Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities PR Newswire SAN DIEGO, March 12, 2026 SAN...

Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026

Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026 Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026 PR Newswire SAN DIEGO, Feb. 23...

Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update

Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update PR Newswire SAN DIEGO, Feb. 12, 2026...

Illustration showing chimeric antigen receptor (CAR) T cells (blue and green) being used to treat non-small cell lung cancer (NSCLC). | Representative image: Getty Images

Why Did Aethlon Medical Stock Tumble Over 12% Today?

Aethlon Medical's stock drew investor attention after the company announced a private placement and warrant inducement deal. 

Equity

Aethlon Medical's stock drew investor attention after the company announced a private placement and warrant inducement deal. 


Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million

Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million Aethlon Medical Announces Pricing of a Private...

Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs

Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier Binds to Extracellular Vesicles in Long COVID patient samples and Decreases...

Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update

Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update PR Newswire SAN DIEGO, Nov. 12, 2025...

What to Expect from Aethlon Medical's Earnings

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025 Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference...

Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce on April 17, 1991 and is headquartered in San Diego, CA.

Current Price	$2.16
Prev Close	$2.30
Open	$2.26
Dividend Yield	0.00%
50-Day Moving Average	$2.23
Beta	0.54
Avg. Volume	32,691.68
PE Ratio	-0.05

52-Week High	$35.20
52-Week Low	$1.36
Market Capitalization	$3.02M
EPS (Annual)	-$85.78
Price to Book	0.31
Revenue Per Employee	$0.00

AEMD
Aethlon Medical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AEMD News

AEMDAethlon Medical Inc